PSY83 - IMPACT OF DOSE ESCALATION ON AVERAGE COST AND COST-EFFECTIVENESS OF ANTI-TNF AND USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN SWEDEN
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2658
https://www.valueinhealthjournal.com/article/S1098-3015(18)35960-6/fulltext
Section Title :
Section Order :
2016
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35960-6&doi=10.1016/j.jval.2018.09.2658